以下文章来源于合成生物学与绿色生物制造 ，作者何玉婷 合成生物学与绿色生物制造 . 全球生物基和生物制造产业服务平台www.bio-basedlink.net | 分享生物制造产业新趋势、新合作和新机遇！ 生物基高分子领域有哪些经济可行性产品？ 生物基高分子 材料存在的问题是什么？有哪些 产业化机会？ 近日， 中国科学院宁波材料技术与工程研究所研究员，浙江省全省生物基高分子材料重点实验室主任 朱锦 分享了《 生物基高分子材料研究新进展 》的精彩报告。【DT新材料 】 做相关内容整理如下，与行业共享、共勉。 如下图所示，理论上，替代石油、煤炭和天然气原料资源，利用以光合作用产生的生物质资源，通过化学法或者微生物法，几乎能得到人类现所用所有 的高分子材料。 图来源：朱锦研究员演讲内容 当然，从经济上看，部分材料经济可行，部分经济不可行。但这也是行业生物基领域的研究和开发重点。 朱锦研究员表示： " 回望聚乳酸价格的发展 历程，实际上我觉得这恰恰说明了，生物质转化为生物基材料这一潜力非常大。" 根据生物基高分子材料产 业链，2018年， 中国科学院宁波材料技术与工程研究所在浙江成立了浙江重点实验室， 重点聚焦三大研 ...

生物基高分子领域有哪些经济可行性产品？ 生物基高分子 材料存在的问题是什么？有哪些 产业化机会？ 8月14日， 中国科学院宁波材料技术与工程研究所研究员，浙江省全省生物基高分子材料重点实验室主任 朱锦 在2025中国合成 树脂产业发展大会上分享了《 生物基高分子材料研究新进展 》。DT新材料【生物基能源与材料】做相关内容整理如下，与行业 共享、共勉。 如下图所示，理论上，替代石油、煤炭和天然气原料资源，利用以光合作用产生的生物质资源，通过化学法或者微生物法，几乎能得 到人类现所用所有的高分子材料。 图来源：朱锦研究员演讲内容 当然，从经济上看，部分材料经济可行，部分经济不可行。但这也是行业生物基领域的研究和开发重点。 朱锦研究员表示： " 回望 聚乳酸价格的发展历程，实际上我觉得这恰恰说明了，生物质转化为生物基材料这一潜力非常大。" 根据生物基高分子材料产 业链，2018年， 中国科学院宁波材料技术与工程研究所在浙江成立了浙江重点实验室， 重点聚焦三大研 究方向 ：1、非粮 生物质基材的高效转化利用技术；2、高品质生物基高分子材料的设计合成；3、生物基高分子材料高质化加工应 用技术。 目前，宁波材料所应该也是 ...

Core Viewpoint - Zhejiang Wansheng Co., Ltd. reported a significant decline in net profit and operating cash flow for the first half of 2025, attributed to increased depreciation and costs related to production capacity ramp-up, despite a rise in revenue due to the consolidation of Guangzhou Entropy New Materials [2][3][4]. Company Overview and Financial Indicators - Company Name: Zhejiang Wansheng Co., Ltd. [2] - Stock Code: 603010 [2] - Revenue for the first half of 2025 reached approximately CNY 1.623 billion, a 17.07% increase from the previous year [3]. - Total profit decreased by 25.85% to approximately CNY 61.064 million [3]. - Net profit attributable to shareholders dropped by 65.02% to approximately CNY 26.323 million [3]. - Operating cash flow decreased by 50.99% to approximately CNY 108.541 million [3]. - Total assets increased slightly by 0.42% to approximately CNY 7.230 billion [3]. Business Segments - The company specializes in functional fine chemicals, focusing on phosphorus-based flame retardants, polymer functional additives, organic amines, and coating additives [4][5]. - The company has established a global sales network with production bases in China and a presence in international markets including the USA, Europe, and Southeast Asia [4]. - The main products include polymer functional additives, organic amines, and coating additives, which are widely used in various industries such as automotive, electronics, and construction [4][5]. Industry Context - The fine chemical industry is a rapidly growing sector, with projections indicating that China's fine chemical market could reach CNY 11 trillion by 2027 [9]. - The phosphorus-based flame retardant market is driven by stringent fire safety regulations in developed countries, leading to increased demand for environmentally friendly alternatives [10][11]. - The demand for engineering plastics, particularly in the automotive and electronics sectors, is expected to grow significantly, driven by trends in lightweight materials and enhanced safety standards [12][14]. - The market for organic amines is expanding due to their wide applications in pharmaceuticals, agriculture, and industrial processes, with a focus on environmentally friendly solutions [20].

Group 1 - The core viewpoint of the article is that Wanhua Chemical has outlined its investment plans for 2024 and 2025, focusing on expanding its production capacity and developing new materials, particularly in the polyurethane and high-performance materials sectors [1][2]. - In 2024, Wanhua Chemical plans to invest a total of 454 billion yuan, with an actual investment completion of 428.3 billion yuan, covering projects related to polyurethane and high-performance materials [1]. - For 2025, the planned investment is 294.3 billion yuan, with a focus on key projects such as MDI capacity expansion and the industrialization of green functional additives and battery materials [1]. Group 2 - The first project mentioned is the HEMA Phase II technical transformation and capacity expansion project, which aims to increase the HEMA production capacity by 20,000 tons per year, bringing the total capacity to 55,000 tons per year [3][4]. - HEMA is a functional organic polymer monomer widely used in medical high polymer materials and various applications such as automotive coatings and 3D printing [4][5]. - The second project is the expansion of the lemon aldehyde HCTA and BRA units, which will increase the MDO capacity from 5,400 tons to 10,000 tons per year [7][8]. - Lemon aldehyde is an important fine chemical widely used in flavors, cosmetics, and pharmaceuticals, particularly as a key intermediate in vitamin A production [7][8].

【DT新材料】 获 悉 ，4月28日， 南京聚隆 发布公告，2025年第一季度，公司实现营业收入为5.95亿元，同比上升32.48%；归母净利润为3052.77万元，同比上升 33.56%；扣非归母净利润为2897.81万元，同比上升26.35%。 | | 本报告期 | 上年同期 | 本报告期比上年同期增减 | | --- | --- | --- | --- | | | | | (%) | | 营业收入(元) | 594, 654, 632. 66 | 448, 876, 171. 94 | 32. 48% | | 归属于上市公司股东的净利 | 30.527.733.41 | 22, 857, 761. 18 | 33.56% | | 润(元) | | | | | 归属于上市公司股东的扣除 | | | | | 非经常性损益的净利润 | 28. 978. 050. 57 | 22, 934, 613. 78 | 26. 35% | | (元) | | | | | 经营活动产生的现金流量净 | -64.164.679.43 | 34.677.076.93 | -285.03% | | 额(元) | | | | 前 ...